Hisamitsu Pharmaceutical Co.,Inc.

4530・Prime Market・Pharmaceuticals

Official website

Hisamitsu Pharmaceutical Co.,Inc.

4530・Prime Market・Pharmaceuticals

Official website

Hisamitsu Pharmaceutical Co.,Inc.4530

Reference Indicators

Market Cap

—

P/E (Forecast)

—

P/B

—

Dividend Yield (Forecast)

—

ROE

6.7%

EV/EBITDA

—

Financial Summary

Unit: ¥M

Item	2022Feb 2022	2023Feb 2023	2024Feb 2024	2025Feb 2025	2026Feb 2026
Net Sales	120,193	128,330	141,706	156,006	163,024
Cost of Sales	50,126	55,630	62,735	64,810	66,903
Gross Profit	70,067	72,699	78,970	91,196	96,121
SG&A Expenses	60,730	61,099	65,803	72,300	78,203
Operating Income	9,337	11,599	13,167	18,895	17,917
Non-operating Income	3,453	4,791	6,605	5,365	6,167
Non-operating Expenses	152	340	123	251	132
Ordinary Income	12,638	16,051	19,649	24,010	23,952
Extraordinary Income	660	453	391	5,044	143
Extraordinary Losses	342	391	854	367	439
Pre-tax Income	12,956	16,113	19,186	28,687	23,656
Income Taxes	3,093	3,987	4,754	6,385	4,104
Net Income	9,658	11,742	13,969	21,758	19,160
EBITDA	13,658	16,551	18,339	25,230	24,968
Gross Margin	58.3%	56.7%	55.7%	58.5%	59.0%
Operating Margin	7.8%	9.0%	9.3%	12.1%	11.0%
ROA	3.2%	3.7%	4.2%	6.3%	5.2%
ROE	3.8%	4.7%	5.4%	8.0%	6.7%

Segment Performance

Unit: ¥M

2025

Segment	Net Sales	Operating Income	Operating Margin
医薬品事業	0	0	0.0%
その他	0	0	0.0%